The results suggest that PPARA presents a tighter connection to CLL and TFS-related gene markers than most (>84%) of the previously reported CLL promoters, indicating the significance of PPARA as a treatment target for CLL. The gene discussed is PPARA; the disease is B-cell chronic lymphocytic leukemia.